CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 81 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,223,793 | +30.5% | 1,236,951 | +49.7% | 0.00% | – |
| Q3 2022 | $5,536,000 | +201.9% | 826,191 | +89.7% | 0.00% | – |
| Q2 2022 | $1,834,000 | +21.5% | 435,478 | -2.8% | 0.00% | – |
| Q1 2022 | $1,510,000 | +6.3% | 447,948 | -0.8% | 0.00% | – |
| Q4 2021 | $1,421,000 | -39.7% | 451,389 | -37.3% | 0.00% | – |
| Q3 2021 | $2,355,000 | -16.7% | 719,973 | +7.5% | 0.00% | – |
| Q2 2021 | $2,827,000 | -75.7% | 670,035 | -71.2% | 0.00% | – |
| Q1 2021 | $11,613,000 | -58.3% | 2,327,218 | +5.6% | 0.00% | -100.0% |
| Q4 2020 | $27,865,000 | +56.1% | 2,204,509 | +21.3% | 0.00% | 0.0% |
| Q3 2020 | $17,847,000 | -1.6% | 1,817,454 | -0.3% | 0.00% | 0.0% |
| Q2 2020 | $18,140,000 | +17.0% | 1,823,084 | +4.0% | 0.00% | 0.0% |
| Q1 2020 | $15,500,000 | +11.5% | 1,753,460 | +16.4% | 0.00% | 0.0% |
| Q4 2019 | $13,899,000 | +35.7% | 1,506,654 | -13.5% | 0.00% | – |
| Q3 2019 | $10,243,000 | -49.7% | 1,741,822 | +2.6% | 0.00% | -100.0% |
| Q2 2019 | $20,365,000 | -2.2% | 1,697,125 | -1.6% | 0.00% | 0.0% |
| Q1 2019 | $20,818,000 | -2.5% | 1,724,712 | +1.4% | 0.00% | 0.0% |
| Q4 2018 | $21,342,000 | -14.3% | 1,700,485 | +1.4% | 0.00% | 0.0% |
| Q3 2018 | $24,893,000 | -9.7% | 1,677,409 | +2.4% | 0.00% | 0.0% |
| Q2 2018 | $27,559,000 | -24.6% | 1,637,459 | +2.7% | 0.00% | -50.0% |
| Q1 2018 | $36,527,000 | -21.0% | 1,595,112 | -10.7% | 0.00% | 0.0% |
| Q4 2017 | $46,210,000 | +175.7% | 1,786,223 | +57.2% | 0.00% | +100.0% |
| Q3 2017 | $16,761,000 | +8.5% | 1,136,415 | +2.6% | 0.00% | 0.0% |
| Q2 2017 | $15,454,000 | -18.6% | 1,107,763 | -0.4% | 0.00% | 0.0% |
| Q1 2017 | $18,976,000 | +72884.6% | 1,112,286 | +44249.5% | 0.00% | – |
| Q4 2016 | $26,000 | -7.1% | 2,508 | -9.1% | 0.00% | – |
| Q3 2016 | $28,000 | +3.7% | 2,758 | +14.4% | 0.00% | – |
| Q2 2016 | $27,000 | +68.8% | 2,411 | +106.8% | 0.00% | – |
| Q1 2016 | $16,000 | +100.0% | 1,166 | +191.5% | 0.00% | – |
| Q3 2015 | $8,000 | -94.5% | 400 | -96.3% | 0.00% | – |
| Q4 2014 | $145,000 | -51.0% | 10,868 | -53.8% | 0.00% | – |
| Q3 2014 | $296,000 | -39.5% | 23,500 | -51.4% | 0.00% | -100.0% |
| Q2 2014 | $489,000 | -24.9% | 48,400 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $651,000 | – | 48,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |